Key Metrics
CiteScore 

4.4
H-Index 

96
SJR 

Q2Pharmacology

SNIP 

0.79
Recommended pre-submission checks
Powered by 

Topics Covered on Naunyn-Schmiedeberg's Archives of Pharmacology
Naunyn-Schmiedeberg's Archives of Pharmacology Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | SPRINGER |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1873 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Naunyn-Schmiedeberg's Archives of Pharmacology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Naunyn-Schmiedeberg's Archives of Pharmacology
The effects of sacubitril/valsartan compared to valsartan in experimentally induced chronic kidney disease.
- 7 Feb 2026
- Naunyn-Schmiedeberg's archives of pharmacology
Retraction Note: Pharmacological evaluation of carvacrol anti-migraine potential.
- 7 Feb 2026
- Naunyn-Schmiedeberg's archives of pharmacology
Pharmacological content in the television series "House MD": analysis from a German pharmacologist's perspective.
- 7 Feb 2026
- Naunyn-Schmiedeberg's archives of pharmacology
Retraction Note: Chronic stress-mediated dysregulations in inflammatory, immune and oxidative circuitry impairs the therapeutic response of methotrexate in experimental autoimmune disease models.
- 7 Feb 2026
- Naunyn-Schmiedeberg's archives of pharmacology
Barriers to effective hypertension control in a low-income healthcare setting: The role of therapeutic inertia and its predictors among hypertensive outpatients.
- 7 Feb 2026
- Naunyn-Schmiedeberg's archives of pharmacology
Convallatoxin ameliorates fibroblast-like synoviocytes-mediated synovial inflammation and joint destruction in rheumatoid arthritis by targeting IDH1.
- 6 Feb 2026
- Naunyn-Schmiedeberg's archives of pharmacology
The effects of sacubitril/valsartan compared to valsartan in experimentally induced chronic kidney disease.
- 7 Feb 2026
- Naunyn-Schmiedeberg's archives of pharmacology
Retraction Note: Pharmacological evaluation of carvacrol anti-migraine potential.
- 7 Feb 2026
- Naunyn-Schmiedeberg's archives of pharmacology
Pharmacological content in the television series "House MD": analysis from a German pharmacologist's perspective.
- 7 Feb 2026
- Naunyn-Schmiedeberg's archives of pharmacology
Retraction Note: Chronic stress-mediated dysregulations in inflammatory, immune and oxidative circuitry impairs the therapeutic response of methotrexate in experimental autoimmune disease models.
- 7 Feb 2026
- Naunyn-Schmiedeberg's archives of pharmacology
Barriers to effective hypertension control in a low-income healthcare setting: The role of therapeutic inertia and its predictors among hypertensive outpatients.
- 7 Feb 2026
- Naunyn-Schmiedeberg's archives of pharmacology
Convallatoxin ameliorates fibroblast-like synoviocytes-mediated synovial inflammation and joint destruction in rheumatoid arthritis by targeting IDH1.
- 6 Feb 2026
- Naunyn-Schmiedeberg's archives of pharmacology